ArticleCancer treatment and research2022

Allogeneic Tumor Antigen-Specific T Cells for Broadly Applicable Adoptive Cell Therapy of Cancer.

Zaki Molvi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.